The Melanoma Research Foundation (MRF) is pleased to share recent significant achievements for the melanoma community. In March 2022, the U.S. Food and Drug Administration ...

On February 25, 2022, the American Cancer Society Cancer Action Network (ACS-CAN) and the National Comprehensive Cancer Network (NCCN) sent a joint letter to the Majority a...

As the MRF observes Rare Disease Day on February 28, 2022, we celebrate the courageous and inspiring members of our community who are living with a rare melanoma subtype. M...

WASHINGTON, DC (February 23, 2022) – The Melanoma Research Foundation (MRF) will host nearly 100 advocates during the all-virtual MRF Advocacy Days held March 7-11, 2022....

Guest blog post by Monique Mack, “In the Sun” documentary participant, melanoma survivor and MRF advocate:   My name is Monique Mack, and I am honored to be an advoca...

Guest blog post by Katonya Breaux, Founder, Unsun Cosmetics and MRF advocate:   I discovered moles on my face that I thought were genetic, but after a visit to the dermato...

Guest blog post by Samantha Buirski, ocular melanoma patient, advocate and member of the CURE OM Patient Steering Committee: Being part of a rare community is challenging. ...

Guest blog post by Kristin R. McJunkins, Stage III melanoma survivor and advocate: In 2008 when I was 38 years old, I was diagnosed with Stage IIIa cutaneous melanoma. Afte...

The MRF is proud to share the following press release from the Congressionally Directed Medical Research Program announcing MRF Board Chair (and melanoma survivor) Doug Bro...

Guest blog post by Richard K. Lodwick, OD: As I explain to most every patient, the view into the eye is a direct view into the body. Within the eye we have access to nerves...

Guest blog post by ocular melanoma patient and advocate Karen Kaludov: When I was in college, a doctor told me my goal was to not get skin cancer before I was 40. The docto...